Alfonso Quintás-Cardama

Statistics

Publications

Citations

391

H-Index

Active since

2006

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Alfonso Quintás-Cardama is an author at The University of Texas MD Anderson Cancer Center specializing in chronic myeloid leukemia therapy, pharmacology, and medicine.

Publications per year

2006–2011

Publications

Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy

Alfonso Quintás-Cardama, Hagop M. Kantarjian, Guillermo Garcia‐Manero et al. · Cancer · 2006 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Bone Marrow Stroma–Secreted Cytokines Protect JAK2V617F-Mutated Cells from the Effects of a JAK2 Inhibitor

Taghi Manshouri, Zeev Estrov, Alfonso Quintás-Cardama et al. · Cancer Research · 2011 · 102 citations · Full text

Medicine, Cell Biology, Pathobiology +16

Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia

Alfonso Quintás-Cardama, Jörge E. Cortes, Susan O’Brien et al. · Cancer · 2009 · 61 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia

Jörge E. Cortes, Alfonso Quintás-Cardama, Dan Jones et al. · Cancer · 2010 · 48 citations · Full text

Life Sciences, Immunology, Pharmacology +13

Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells

Nada Oršolić, Mirna Golemović, Alfonso Quintás-Cardama et al. · Cancer Science · 2006 · 21 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 7